Overview
Nicholas Vitanza is a Pediatric Hematologist Oncology provider in Seattle, Washington. Dr. Vitanza is rated as an Elite provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, Glioma, and Medulloblastoma.
His clinical research consists of co-authoring 73 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 17 articles and participated in 1 clinical trial in the study of Diffuse Midline Glioma H3 K27M-Mutant.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- PPO
- EPO
- PPO
Locations
Additional Areas of Focus
Dr. Vitanza has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Sarah Leary is a Pediatric Hematologist Oncology provider in Seattle, Washington. Dr. Leary is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Medulloblastoma, Glioma, Embryonal Tumor with Multilayered Rosettes, Diffuse Midline Glioma H3 K27M-Mutant, and Bone Marrow Aspiration.
James Olson is a Pediatric Hematologist Oncology provider in Seattle, Washington. Dr. Olson is rated as a Distinguished provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. His top areas of expertise are Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Diffuse Midline Glioma H3 K27M-Mutant.
The Association Of Chrmc And University Physicians
Erin Crotty is a Pediatric Hematologist Oncology provider in Seattle, Washington. Dr. Crotty is rated as an Advanced provider by MediFind in the treatment of Diffuse Midline Glioma H3 K27M-Mutant. Her top areas of expertise are Retinoblastoma, Glioma, Medulloblastoma, and Hereditary Retinoblastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Diffuse Midline Glioma H3 K27M-Mutant
- Distinguished
- Brain Stem CancerDr. Vitanza isDistinguished. Learn about Brain Stem Cancer.
- GliomaDr. Vitanza isDistinguished. Learn about Glioma.
- Advanced
- Embryonal Tumor with Multilayered Rosettes
- MedulloblastomaDr. Vitanza isAdvanced. Learn about Medulloblastoma.
- PineocytomaDr. Vitanza isAdvanced. Learn about Pineocytoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Vitanza isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Congenital Aplastic AnemiaDr. Vitanza isExperienced. Learn about Congenital Aplastic Anemia.
- Fanconi AnemiaDr. Vitanza isExperienced. Learn about Fanconi Anemia.
- Infantile NeutropeniaDr. Vitanza isExperienced. Learn about Infantile Neutropenia.
- LeukemiaDr. Vitanza isExperienced. Learn about Leukemia.
- Pediatric Low-Grade Glioma (pLGG)Dr. Vitanza isExperienced. Learn about Pediatric Low-Grade Glioma (pLGG).